Eric Richfield

Dr. Eric Richfield is a distinguished board-certified Neurologist and Neuropathologist with a profound background in clinical and research neuroscience. His remarkable career includes holding M.D. and Ph.D. degrees, multiple residencies in Neurology, Pathology, and Neuropathology, and over 15 years as a dedicated independent researcher. Dr. Richfield's expertise spans a wide range of medical fields, from patient care to clinical and forensic neuropathology, with impactful contributions to the legal and federal systems, including the FDA. He is a sought-after consultant for universities, pharmaceutical companies, and the Federal Government, particularly in the realm of technologies for clinical and research neuropathology. Dr. Richfield has been the recipient of prestigious funding from esteemed institutions such as the National Institutes of Health, the Department of Defense, private foundations like the Tourette Syndrome Association and the Huntington’s Disease Society of America, as well as industry giant Elan Pharmaceuticals. Currently, he holds the position of Associate Professor of Pathology and Laboratory Medicine at Rutgers University, where he conducts cutting-edge research and practices clinical Neuropathology. Moreover, Dr. Richfield is recognized for his entrepreneurial spirit as the founder and Director of the Molecular Histology Center at EOHS/Rutgers, a renowned facility known for its intricate molecular histological techniques that cater to academic labs and pharmaceutical/biotech companies globally. He is esteemed by his peers as an authority in advanced molecular histology techniques.